.ALX Oncology's stage 2 stomach cancer feedback fee has actually deteriorated. After seeing its CD47...
.Another of Ionis Pharmaceuticals' crucial midphase readouts has disappointed requirements, motivati...
.While Biogen's pharma peers are looking for late-stage properties along with little threat, CEO Chr...
.Instil Bio has been a biotech looking for a pipeline after it scrapped its own lead resources over ...
.Biogen has restored civil rights to an early Alzheimer's health condition plan to Denali Therapies,...
.Welcome to recently's Chutes & Ladders, our summary of substantial management hirings, firings a...
.Vertex's effort to address an unusual genetic ailment has attacked yet another problem. The biotech...
.Vir Biotechnology's second-quarter earnings report had not been short of big news. The provider wel...
.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T cell therapy, pushin...
.After much more than three decades, genetics treatment trailblazer James Wilson M.D., Ph.D., is act...